JP4624566B2 - 高密度の細胞を産生および使用するための装置および方法およびそこからの産物 - Google Patents
高密度の細胞を産生および使用するための装置および方法およびそこからの産物 Download PDFInfo
- Publication number
- JP4624566B2 JP4624566B2 JP2000597414A JP2000597414A JP4624566B2 JP 4624566 B2 JP4624566 B2 JP 4624566B2 JP 2000597414 A JP2000597414 A JP 2000597414A JP 2000597414 A JP2000597414 A JP 2000597414A JP 4624566 B2 JP4624566 B2 JP 4624566B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- oxygen
- cell
- bioreactor
- cell culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 142
- 241000701447 unidentified baculovirus Species 0.000 claims abstract description 49
- 210000004027 cell Anatomy 0.000 claims description 503
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 322
- 239000001301 oxygen Substances 0.000 claims description 322
- 229910052760 oxygen Inorganic materials 0.000 claims description 322
- 238000004113 cell culture Methods 0.000 claims description 147
- 239000002609 medium Substances 0.000 claims description 135
- 238000000502 dialysis Methods 0.000 claims description 106
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 92
- 239000012510 hollow fiber Substances 0.000 claims description 92
- 241000238631 Hexapoda Species 0.000 claims description 74
- 239000001963 growth medium Substances 0.000 claims description 68
- 239000013598 vector Substances 0.000 claims description 64
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 50
- 230000014509 gene expression Effects 0.000 claims description 47
- 239000001569 carbon dioxide Substances 0.000 claims description 46
- 239000000047 product Substances 0.000 claims description 45
- 241000700605 Viruses Species 0.000 claims description 33
- 238000005259 measurement Methods 0.000 claims description 28
- 239000012528 membrane Substances 0.000 claims description 27
- 230000004087 circulation Effects 0.000 claims description 26
- 230000008569 process Effects 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 21
- 238000005507 spraying Methods 0.000 claims description 19
- 239000000126 substance Substances 0.000 claims description 19
- 210000003040 circulating cell Anatomy 0.000 claims description 15
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims description 14
- 230000000153 supplemental effect Effects 0.000 claims description 14
- 108020004707 nucleic acids Proteins 0.000 claims description 10
- 102000039446 nucleic acids Human genes 0.000 claims description 10
- 150000007523 nucleic acids Chemical class 0.000 claims description 10
- 230000004044 response Effects 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 9
- 238000011144 upstream manufacturing Methods 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 6
- 239000012577 media supplement Substances 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 238000009529 body temperature measurement Methods 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 11
- 241000256251 Spodoptera frugiperda Species 0.000 abstract description 6
- 238000001727 in vivo Methods 0.000 abstract description 2
- 102000003951 Erythropoietin Human genes 0.000 abstract 2
- 108090000394 Erythropoietin Proteins 0.000 abstract 2
- 229940105423 erythropoietin Drugs 0.000 abstract 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 abstract 2
- 101150002621 EPO gene Proteins 0.000 abstract 1
- 101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 abstract 1
- 101000920686 Homo sapiens Erythropoietin Proteins 0.000 abstract 1
- 102000044890 human EPO Human genes 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 description 74
- 239000002699 waste material Substances 0.000 description 44
- 239000000523 sample Substances 0.000 description 43
- 238000004519 manufacturing process Methods 0.000 description 38
- 239000007789 gas Substances 0.000 description 32
- 230000012010 growth Effects 0.000 description 28
- 108090000623 proteins and genes Proteins 0.000 description 28
- 230000010261 cell growth Effects 0.000 description 21
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 20
- 208000015181 infectious disease Diseases 0.000 description 20
- 239000012620 biological material Substances 0.000 description 19
- 230000006870 function Effects 0.000 description 19
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 16
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 16
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 16
- 239000008103 glucose Substances 0.000 description 16
- 239000003570 air Substances 0.000 description 15
- 102000004169 proteins and genes Human genes 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 14
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 13
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 13
- 239000006143 cell culture medium Substances 0.000 description 13
- 239000000839 emulsion Substances 0.000 description 13
- 238000010586 diagram Methods 0.000 description 12
- 239000011148 porous material Substances 0.000 description 12
- 239000000700 radioactive tracer Substances 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 101710182846 Polyhedrin Proteins 0.000 description 10
- 229910021529 ammonia Inorganic materials 0.000 description 10
- 210000004102 animal cell Anatomy 0.000 description 9
- 239000006285 cell suspension Substances 0.000 description 9
- 230000008859 change Effects 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 239000013604 expression vector Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000003633 blood substitute Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000010412 perfusion Effects 0.000 description 8
- 101710154606 Hemagglutinin Proteins 0.000 description 7
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 7
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 7
- 101710176177 Protein A56 Proteins 0.000 description 7
- 230000035508 accumulation Effects 0.000 description 7
- 238000009825 accumulation Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 230000000670 limiting effect Effects 0.000 description 7
- 210000004962 mammalian cell Anatomy 0.000 description 7
- 230000002503 metabolic effect Effects 0.000 description 7
- 230000008929 regeneration Effects 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 238000005070 sampling Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 230000014616 translation Effects 0.000 description 7
- 239000002028 Biomass Substances 0.000 description 6
- 108091029865 Exogenous DNA Proteins 0.000 description 6
- 238000013019 agitation Methods 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000003792 electrolyte Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000000185 hemagglutinin Substances 0.000 description 6
- 238000001139 pH measurement Methods 0.000 description 6
- 230000002572 peristaltic effect Effects 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 238000001890 transfection Methods 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 5
- 230000030833 cell death Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 206010022000 influenza Diseases 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 238000006213 oxygenation reaction Methods 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 230000035440 response to pH Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 230000009469 supplementation Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- 241000271566 Aves Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 210000004748 cultured cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 229910001882 dioxygen Inorganic materials 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012737 fresh medium Substances 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 239000012679 serum free medium Substances 0.000 description 3
- 150000003384 small molecules Chemical group 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000701161 unidentified adenovirus Species 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000699802 Cricetulus griseus Species 0.000 description 2
- 108010041986 DNA Vaccines Proteins 0.000 description 2
- 229940021995 DNA vaccine Drugs 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 241000255777 Lepidoptera Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000270295 Serpentes Species 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000000385 dialysis solution Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000011325 microbead Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000004017 serum-free culture medium Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000011476 stem cell transplantation Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 241000710929 Alphavirus Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000701822 Bovine papillomavirus Species 0.000 description 1
- 241000269420 Bufonidae Species 0.000 description 1
- 241000269333 Caudata Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 description 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- WMFYOYKPJLRMJI-UHFFFAOYSA-N Lercanidipine hydrochloride Chemical compound Cl.COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 WMFYOYKPJLRMJI-UHFFFAOYSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000714177 Murine leukemia virus Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000321461 Mycteroperca phenax Species 0.000 description 1
- 208000007201 Myocardial reperfusion injury Diseases 0.000 description 1
- GIYXAJPCNFJEHY-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine hydrochloride (1:1) Chemical compound Cl.C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 GIYXAJPCNFJEHY-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 241001327682 Oncorhynchus mykiss irideus Species 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 241001625943 Panulirus penicillatus Species 0.000 description 1
- 241000927735 Penaeus Species 0.000 description 1
- 240000003296 Petasites japonicus Species 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 208000005585 Poxviridae Infections Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 241000256248 Spodoptera Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108091005735 TGF-beta receptors Proteins 0.000 description 1
- 102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 description 1
- 241000255985 Trichoplusia Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000193453 [Clostridium] cellulolyticum Species 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 230000035071 co-translational protein modification Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000011018 current good manufacturing practice Methods 0.000 description 1
- 238000010217 densitometric analysis Methods 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- -1 diagnostics Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229940068998 egg yolk phospholipid Drugs 0.000 description 1
- 239000008344 egg yolk phospholipid Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000011194 good manufacturing practice Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 239000000004 hemodialysis solution Substances 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 102000055647 human CSF2RB Human genes 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000012194 insect media Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000003914 myeloid leukocyte Anatomy 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000002689 xenotransplantation Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
- C12M27/02—Stirrer or mobile mixing elements
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/06—Nozzles; Sprayers; Spargers; Diffusers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/16—Hollow fibers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/18—External loop; Means for reintroduction of fermented biomass or liquid percolate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/26—Conditioning fluids entering or exiting the reaction vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/12—Means for regulation, monitoring, measurement or control, e.g. flow regulation of temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/26—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pH
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
- C12M41/32—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of substances in solution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
- C12M41/36—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of biomass, e.g. colony counters or by turbidity measurements
Landscapes
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11881699P | 1999-02-05 | 1999-02-05 | |
| US60/118,816 | 1999-02-05 | ||
| US16235499P | 1999-10-29 | 1999-10-29 | |
| US60/162,354 | 1999-10-29 | ||
| US09/484,886 US8026096B1 (en) | 1998-10-08 | 2000-01-18 | In vivo active erythropoietin produced in insect cells |
| US09/484,886 | 2000-01-18 | ||
| PCT/US2000/001568 WO2000046354A1 (en) | 1999-02-05 | 2000-01-21 | Apparatus and methods for producing and using high-density cells and products therefrom |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003521877A JP2003521877A (ja) | 2003-07-22 |
| JP2003521877A5 JP2003521877A5 (https=) | 2007-03-15 |
| JP4624566B2 true JP4624566B2 (ja) | 2011-02-02 |
Family
ID=27382223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000597414A Expired - Fee Related JP4624566B2 (ja) | 1999-02-05 | 2000-01-21 | 高密度の細胞を産生および使用するための装置および方法およびそこからの産物 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8026096B1 (https=) |
| EP (1) | EP1157098B1 (https=) |
| JP (1) | JP4624566B2 (https=) |
| AT (1) | ATE408673T1 (https=) |
| CA (1) | CA2360916C (https=) |
| DE (1) | DE60040271D1 (https=) |
| DK (1) | DK1157098T3 (https=) |
| HK (1) | HK1043153B (https=) |
| WO (1) | WO2000046354A1 (https=) |
Families Citing this family (95)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19945162A1 (de) * | 1999-09-21 | 2001-04-26 | Herbert Maerkl | Verfahren zur Kultivierung von Zellen, Membranmodul, Verwendung eines Membranmoduls und Reaktionssystem zur Kultivierung von Zellen |
| US7160719B2 (en) | 2002-06-07 | 2007-01-09 | Mayo Foundation For Medical Education And Research | Bioartificial liver system |
| US8541003B2 (en) | 2003-06-20 | 2013-09-24 | Protein Sciences Corporation | Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| CA2557046A1 (en) * | 2004-03-05 | 2005-10-13 | John Crowley | Process for cell culturing by continuous perfusion and alternating tangential flow |
| DK1773976T4 (da) | 2004-06-04 | 2020-02-10 | Global Life Sciences Solutions Usa Llc | Engangsbioreaktorsystemer og -fremgangsmåder |
| ITPI20040046A1 (it) * | 2004-06-18 | 2004-09-18 | Univ Pisa | Bioreattore per lo studio degli effetti sulle attivita' cellulari di stimoli imposti |
| US8153435B1 (en) | 2005-03-30 | 2012-04-10 | Tracer Detection Technology Corp. | Methods and articles for identifying objects using encapsulated perfluorocarbon tracers |
| KR100766885B1 (ko) * | 2006-04-14 | 2007-10-18 | 신윤호 | 온라인 분석기용 울트라 필터레이션 시스템 |
| JP2010507068A (ja) * | 2006-04-21 | 2010-03-04 | バイエル・コーポレーシヨン | 原位置測定のための装置、システム、方法 |
| KR101685246B1 (ko) | 2006-07-14 | 2016-12-09 | 디피엑스 홀딩스 비.브이. | 개선된 세포 배양 방법 |
| GB0621452D0 (en) * | 2006-10-27 | 2006-12-06 | Ucl Business Plc | Therapy for liver disease |
| MX2009007893A (es) * | 2007-01-25 | 2009-08-21 | Amprotein Corp | Uso del intron-1 de gen de beta actina de pollo. |
| WO2009016078A2 (en) * | 2007-07-31 | 2009-02-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for culturing mammalian stem cells |
| WO2009018851A1 (de) * | 2007-08-06 | 2009-02-12 | Siemens Aktiengesellschaft | Verfahren zum anwesenheitsnachweis von mikroorganismen in einem bioreaktor, bioreaktor und anordnung |
| TWI325401B (en) * | 2007-12-17 | 2010-06-01 | Duen Gang Mou | Vessel structure |
| EP2330209B1 (en) | 2008-09-30 | 2017-07-19 | Toray Industries, Inc. | Method and apparatus for producing a chemical and continuous culture system |
| WO2010059590A1 (en) * | 2008-11-20 | 2010-05-27 | Waters Technologies Corporation | Apparatus and method for the study of metabolism |
| CN102421467B (zh) | 2009-03-13 | 2015-04-22 | 梅约医学教育与研究基金会 | 生物人工肝 |
| BR112012000242B1 (pt) | 2009-07-06 | 2019-07-09 | Genentech Inc | Métodos para cultivo em batelada de células eucariontes |
| US20110117538A1 (en) * | 2009-11-13 | 2011-05-19 | Niazi Sarfaraz K | Bioreactors for fermentation and related methods |
| EP2525899A1 (en) * | 2010-01-22 | 2012-11-28 | Lonza Walkersville, Inc. | High yield method and apparatus for volume reduction and washing of therapeutic cells using tangential flow filtration |
| JP5810478B2 (ja) * | 2010-01-27 | 2015-11-11 | 株式会社Ihi | 培養情報生成装置及び培養装置並びに培養方法 |
| US20120058534A1 (en) * | 2010-03-09 | 2012-03-08 | Stover & Associates, Inc. | Optimized biogas (biomethane) production process |
| WO2012048276A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
| BRPI1005896B1 (pt) * | 2010-12-15 | 2019-12-17 | Petroleo Brasileiro S.A. - Petrobras | sistema para obtenção de bioprodutos |
| WO2013048546A1 (en) * | 2011-03-29 | 2013-04-04 | Yongxin Zhang | Multifunctional bioreactor system and methods for cell sorting and culturing |
| KR101282625B1 (ko) * | 2011-05-12 | 2013-07-12 | 명지대학교 산학협력단 | 중공사막을 이용한 미세조류 배양용 고속 광생물 반응장치 |
| EP2710118B1 (en) | 2011-05-17 | 2018-02-07 | Terumo BCT, Inc. | Systems and methods for expanding high density non-adherent cells |
| US20120301923A1 (en) * | 2011-05-27 | 2012-11-29 | Roche Diagnostics Operations, Inc. | Dialysis fermenter-bioreactor with dialysis device |
| US20120308538A1 (en) * | 2011-05-31 | 2012-12-06 | Ursula Bond | Preventing spoilage in alcohol fermentations |
| WO2013063129A1 (en) * | 2011-10-25 | 2013-05-02 | Hyclone Laboratories, Inc. | Fluid mixing systems with adjustable mixing element |
| US10428309B2 (en) | 2011-12-01 | 2019-10-01 | New York Stem Cell Foundation, Inc. | Systems and methods for producing stem cells and differentiated cells |
| ES2773863T3 (es) | 2011-12-01 | 2020-07-15 | New York Stem Cell Found Inc | Sistema automatizado para la producción de células madre pluripotentes inducidas o células diferenciadas |
| US20130260364A1 (en) * | 2012-03-30 | 2013-10-03 | Yongxin Zhang | Multifunctional Bioreactor system and methods for cell sorting and culturing |
| US10717961B2 (en) | 2012-04-27 | 2020-07-21 | Asahi Kasei Kabushiki Kaisha | Cell culture system and cell culture method |
| US9683207B2 (en) * | 2012-05-01 | 2017-06-20 | FiberCell Production Solutions LLC | Method for growing cells in hollow fibers |
| CN104583386A (zh) * | 2012-08-20 | 2015-04-29 | 泰尔茂比司特公司 | 浓缩穿过细胞生长腔室循环的流体的组分 |
| JP6679479B2 (ja) * | 2013-07-17 | 2020-04-15 | サイナス・セル・エクスパンジョン・ベー・フェー | 培地中に溶解されたガスおよびｐＨの制御 |
| WO2015073913A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
| EP3105311A1 (en) | 2014-02-10 | 2016-12-21 | Univercells NV | System, apparatus and method for biomolecules production |
| WO2015118148A1 (en) * | 2014-02-10 | 2015-08-13 | Univercells Nv | System, apparatus and method for biomolecules production |
| WO2015118149A1 (en) * | 2014-02-10 | 2015-08-13 | Univercells Nv | System, apparatus and method for anti-rsv antibodies and formulations |
| WO2015148704A1 (en) | 2014-03-25 | 2015-10-01 | Terumo Bct, Inc. | Passive replacement of media |
| EP3198006B1 (en) | 2014-09-26 | 2021-03-24 | Terumo BCT, Inc. | Scheduled feed |
| DE102014018697A1 (de) * | 2014-12-18 | 2016-06-23 | Erwin Sander Elektroapparatebau Gmbh | Anlage und Steuerungsverfahren zur Zucht von phototrophen Organismen |
| AU2016218037B2 (en) * | 2015-02-09 | 2020-12-17 | Univercells Technologies S.A. | System, apparatus and method for the production of cells and/or cell products |
| BE1022269B1 (fr) * | 2015-02-09 | 2016-03-08 | Univercells Sa | Système, appareil et procédé pour la production de cellules et/ou de produits cellulaires |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| CN104932203A (zh) * | 2015-07-10 | 2015-09-23 | 深圳市华星光电技术有限公司 | 一种光阻汲取装置 |
| WO2017180814A1 (en) * | 2016-04-15 | 2017-10-19 | Boehringer Ingelheim International Gmbh | Cell retention device and method |
| US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| EP3481191A2 (en) * | 2016-07-11 | 2019-05-15 | Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. | Systems and methods for growing cells in vitro |
| TWI648398B (zh) * | 2016-08-02 | 2019-01-21 | 智水科技有限公司 | 微生物培養濃縮過濾系統 |
| EP3510161A4 (en) | 2016-08-23 | 2020-04-22 | Akouos, Inc. | COMPOSITIONS AND METHODS FOR TREATING PERSONAL HEARING LOSS IN A PERSON |
| CN114471268B (zh) | 2016-11-01 | 2024-05-24 | 生命科技股份有限公司 | 具有可垂直调整的混合元件的液体混合系统及其使用方法 |
| US20200063086A1 (en) * | 2016-12-21 | 2020-02-27 | Hoffmann-La Roche Inc. | Growth control of eukaryotic cells |
| KR102318710B1 (ko) * | 2017-01-20 | 2021-10-27 | 후지필름 가부시키가이샤 | 세포 배양 장치 및 세포 배양 방법 |
| EP3592835B1 (en) * | 2017-03-10 | 2022-04-06 | Dow Global Technologies LLC | Aerobic fermentation systems and methods |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| CN117247899A (zh) | 2017-03-31 | 2023-12-19 | 泰尔茂比司特公司 | 细胞扩增 |
| US12234441B2 (en) | 2017-03-31 | 2025-02-25 | Terumo Bct, Inc. | Cell expansion |
| US10774297B2 (en) * | 2017-08-03 | 2020-09-15 | Repligen Corporation | Method of actuation of an alternating tangential flow diaphragm pump |
| WO2019226618A1 (en) * | 2018-05-22 | 2019-11-28 | Nantkwest, Inc. | Methods and systems for cell bed formation during bioprocessing |
| WO2020076776A1 (en) * | 2018-10-10 | 2020-04-16 | Boehringer Ingelheim International Gmbh | Method for membrane gas transfer in high density bioreactor culture |
| KR102871263B1 (ko) * | 2018-11-08 | 2025-10-16 | 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. | 부착 비의존성 세포 및 그 용도 |
| US10647954B1 (en) | 2018-11-15 | 2020-05-12 | Flaskworks, Llc | Dendritic cell generating apparatus and method |
| US11651188B1 (en) | 2018-11-21 | 2023-05-16 | CCLabs Pty Ltd | Biological computing platform |
| US12478571B2 (en) | 2018-12-17 | 2025-11-25 | Pontis Biologics, Inc. | Enzyme based compositions and methods for removing dental calculi |
| JP7231425B2 (ja) * | 2019-02-06 | 2023-03-01 | 株式会社日立製作所 | 培養システム、培養方法及び培養生産物の生産方法 |
| CN109943482B (zh) * | 2019-03-06 | 2022-03-29 | 江苏惠利生物科技有限公司 | 一种利用酶膜反应器耦合萃取制备r-4-氯-3-羟基丁酸乙酯的方法 |
| JP7390677B2 (ja) * | 2019-03-26 | 2023-12-04 | キヤノン株式会社 | 細胞懸濁液処理装置 |
| JP7297208B2 (ja) * | 2019-03-26 | 2023-06-26 | 株式会社京都製作所 | 細胞懸濁液処理装置 |
| WO2020206121A2 (en) * | 2019-04-03 | 2020-10-08 | Flaskworks, Llc | Cell culture systems and uses thereof |
| US11898135B1 (en) * | 2019-07-01 | 2024-02-13 | CCLabs Pty Ltd | Closed-loop perfusion circuit for cell and tissue cultures |
| US11566217B2 (en) | 2019-08-13 | 2023-01-31 | Flaskworks, Llc | Duty cycle for cell culture systems |
| DE102019007144A1 (de) * | 2019-10-15 | 2021-04-15 | ProMedTec Germany GmbH | Verfahren und Anordnung zur Verbesserung des Austausches von Gasen über semipermeable Membranen im wässrigen Milieu |
| CN114901799A (zh) | 2019-10-21 | 2022-08-12 | 弗拉斯沃克斯有限责任公司 | 用于细胞培养的系统和方法 |
| JP7582609B2 (ja) * | 2019-11-20 | 2024-11-13 | 株式会社島津製作所 | 共培養装置及び共培養方法 |
| CN115443330A (zh) * | 2019-12-02 | 2022-12-06 | 奥方特蛋白质科技有限公司 | 使用体外细胞培养生产肉类的方法 |
| CN114945659A (zh) * | 2020-01-02 | 2022-08-26 | 豪夫迈·罗氏有限公司 | 具有一个或多个原位在线传感器的一次性细胞培养容器 |
| CN111154647A (zh) * | 2020-01-17 | 2020-05-15 | 英诺维尔智能科技（苏州）有限公司 | 一种封闭循环外交换生物制品反应器 |
| KR20220157944A (ko) | 2020-02-21 | 2022-11-29 | 아카우오스, 인크. | 인간 대상체에서 비-연령-연관 청각 장애를 치료하기 위한 조성물 및 방법 |
| CN111304067A (zh) * | 2020-03-10 | 2020-06-19 | 北京好思康科技有限公司 | 一种间歇式清洗过滤系统 |
| CN116601279A (zh) * | 2020-07-28 | 2023-08-15 | 思进股份有限公司 | 用于生产多肽的方法和系统 |
| HRP20251349T1 (hr) * | 2021-03-16 | 2025-12-19 | Swissmeca Sa | Epruveta za uzorak i postupak za raspršivanje i homogenizaciju |
| EP4314244B1 (en) | 2021-03-23 | 2025-07-23 | Terumo BCT, Inc. | Cell capture and expansion |
| EP4396324A1 (en) * | 2021-09-30 | 2024-07-10 | Terumo Kabushiki Kaisha | Cell culturing device and cell culturing system |
| CN114317228B (zh) * | 2021-11-29 | 2022-08-19 | 广西银丰干细胞工程技术有限公司 | 一种干细胞培养装置及其培养方法 |
| US20230242864A1 (en) * | 2022-01-31 | 2023-08-03 | Sciperio, Inc | In-time storage of manufactured cells for medical cellular therapy grown and differentiated in bioreactors |
| US12209689B2 (en) | 2022-02-28 | 2025-01-28 | Terumo Kabushiki Kaisha | Multiple-tube pinch valve assembly |
| US12612589B2 (en) * | 2022-05-06 | 2026-04-28 | Sciperio, Inc | Integrated waste removal system for cell culture bioreactor |
| SE2230210A1 (en) * | 2022-06-24 | 2023-12-25 | Fixell Biotech Ab | High eukaryotic cell density transient transfection process for manufacturing of recombinant viral vectors |
| USD1099116S1 (en) | 2022-09-01 | 2025-10-21 | Terumo Bct, Inc. | Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1220745A (en) * | 1982-12-20 | 1987-04-21 | Gary S. Bild | Biocatalytic reactor |
| JPS6188872A (ja) * | 1984-10-09 | 1986-05-07 | Snow Brand Milk Prod Co Ltd | 高濃度連続培養方法及び装置 |
| US4889812A (en) * | 1986-05-12 | 1989-12-26 | C. D. Medical, Inc. | Bioreactor apparatus |
| US4885087A (en) * | 1986-11-26 | 1989-12-05 | Kopf Henry B | Apparatus for mass transfer involving biological/pharmaceutical media |
| JPH01225475A (ja) * | 1988-03-07 | 1989-09-08 | Japan Gore Tex Inc | 培養装置 |
| US5605835A (en) * | 1988-05-23 | 1997-02-25 | Regents Of The University Of Minnesota | Bioreactor device with application as a bioartificial liver |
| US5002890A (en) * | 1988-11-29 | 1991-03-26 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Spiral vane bioreactor |
| US5763266A (en) * | 1989-06-15 | 1998-06-09 | The Regents Of The University Of Michigan | Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells |
| US5656421A (en) | 1990-02-15 | 1997-08-12 | Unisyn Technologies, Inc. | Multi-bioreactor hollow fiber cell propagation system and method |
| WO1994026087A2 (en) * | 1993-05-14 | 1994-11-24 | Connor Kim C O | Recombinant protein production and insect cell culture and process |
| ES2370937T3 (es) * | 1993-09-13 | 2011-12-23 | Protein Sciences Corporation | Un método para producir vacunas antigripales polivalentes a base de hemaglutinina. |
| US5762939A (en) * | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
| US5911982A (en) * | 1995-10-06 | 1999-06-15 | National Science Council | Hz-1 virus persistence-associated-gene 1 (PAG1) promoter uses therefor, and compositions containing same or products therefrom |
| US6103526A (en) * | 1998-10-08 | 2000-08-15 | Protein Sciences Corporation | Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using |
-
2000
- 2000-01-18 US US09/484,886 patent/US8026096B1/en not_active Expired - Fee Related
- 2000-01-21 HK HK02103890.3A patent/HK1043153B/en not_active IP Right Cessation
- 2000-01-21 DK DK00908336T patent/DK1157098T3/da active
- 2000-01-21 JP JP2000597414A patent/JP4624566B2/ja not_active Expired - Fee Related
- 2000-01-21 EP EP00908336A patent/EP1157098B1/en not_active Expired - Lifetime
- 2000-01-21 DE DE60040271T patent/DE60040271D1/de not_active Expired - Lifetime
- 2000-01-21 AT AT00908336T patent/ATE408673T1/de not_active IP Right Cessation
- 2000-01-21 CA CA2360916A patent/CA2360916C/en not_active Expired - Fee Related
- 2000-01-21 WO PCT/US2000/001568 patent/WO2000046354A1/en not_active Ceased
-
2005
- 2005-04-01 US US11/097,994 patent/US7598075B2/en not_active Expired - Fee Related
-
2009
- 2009-10-05 US US12/573,468 patent/US7879601B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1157098B1 (en) | 2008-09-17 |
| HK1043153A1 (en) | 2002-09-06 |
| JP2003521877A (ja) | 2003-07-22 |
| DE60040271D1 (de) | 2008-10-30 |
| DK1157098T3 (da) | 2009-02-02 |
| WO2000046354A8 (en) | 2001-07-12 |
| CA2360916A1 (en) | 2000-08-10 |
| US20100159524A1 (en) | 2010-06-24 |
| US20060019385A1 (en) | 2006-01-26 |
| US7879601B2 (en) | 2011-02-01 |
| US8026096B1 (en) | 2011-09-27 |
| ATE408673T1 (de) | 2008-10-15 |
| EP1157098A1 (en) | 2001-11-28 |
| US7598075B2 (en) | 2009-10-06 |
| EP1157098A4 (en) | 2002-04-17 |
| WO2000046354A1 (en) | 2000-08-10 |
| HK1043153B (en) | 2009-01-30 |
| CA2360916C (en) | 2013-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4624566B2 (ja) | 高密度の細胞を産生および使用するための装置および方法およびそこからの産物 | |
| US10100277B2 (en) | Pluripotent stem cell expansion and passage using a stirred tank bioreactor | |
| US4999298A (en) | Hollow fiber bioreactor culture system and method | |
| US20110212493A1 (en) | Perfusion bioreactors, cell culture systems, and methods for production of cells and cell-derived products | |
| US20070122904A1 (en) | Method and apparatus for culturing cells | |
| Eibl et al. | Application of disposable bag-bioreactors in tissue engineering and for the production of therapeutic agents | |
| WO2001023520A1 (en) | Method and apparatus for culturing cells | |
| CN108866013B (zh) | 一种大规模生产慢病毒的方法 | |
| CN102703319B (zh) | 贴壁型细胞培养装置及贴壁型细胞培养系统 | |
| Raj et al. | 03 Fermentation Technology and Bioreactor Design | |
| AU2005200275B2 (en) | Apparatus and methods for producing and using high-density cells and products therefrom | |
| Reuveny et al. | Apparatus and methodology for microcarrier cell culture | |
| AU2970200A (en) | Apparatus and methods for producing and using high-density cells and products therefrom | |
| AU2008203548A1 (en) | Apparatus and methods for producing and using high-density cells and products therefrom | |
| WO2024104434A1 (zh) | 用于生产目标物质的系统和方法 | |
| US20230001356A1 (en) | In situ filtration for a biocontainer | |
| Norris et al. | Growth of cell lines in bioreactors | |
| AU781265B2 (en) | Method and apparatus for culturing cells | |
| WO2025141177A1 (en) | Recycling media in suspended fluid bed reactor | |
| WO2025141179A1 (en) | Gas exchange device for cell culture bioreactor | |
| Kalthod | Novel carrier and reactor for culture of attachment dependent mammalian cells | |
| CN107460160A (zh) | 一种cho细胞无血清培养基 | |
| BOND et al. | Amicon Division, WR Grace & Co.-Conn. 72 Cherry Hill Drive | |
| Bond et al. | An Automated System for Hollow Fiber Cell Culture | |
| BOND et al. | Amicon Division, WR Grace & Co.-Conn. 72 Cherry Hill Drive Beverly, ΜΑ 01915 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070119 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070119 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091104 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100122 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100129 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100302 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100330 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100629 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100727 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100902 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20101005 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101104 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131112 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |